Skip to main content
  • Call for Papers: Emerging Concepts in Neurodegenerative Diseases

    The journal is calling for submissions of review articles and primary research papers to a new series that addresses various aspects of neurodegenerative diseases. You can learn more about the scope of the series here

    Series Editors: Hui Zheng (Baylor College of Medicine) & Lin Mei (Case Western Reserve University)

    Submission Deadline: November 30, 2021

    Submit your manuscript.

  • Call for Papers: Frontiers in Virology and COVID-19

    As we continue to grapple the COVID-19 pandemic around the globe, the Society of Chinese Bioscientists in America-Virology Division and Cell in& Bioscience announce a call for papers on the current state of virology and COVID-19. Learn more about the series here.

    Series Editors: Dong-Yan Jin (University of Hong Kong), Zhi-Ming Zheng (NCI, National Institutes of Health), and Shan-Lu Liu (The Ohio State University)

    Submission deadline: November 30, 2021

    Submit your manuscript

  • Call for Papers: The human Y chromosome in health and disease

    The journal is calling for submissions to a new series that explores the role of the Y chromosome in development and disease. Learn more about the series here.

    Series Editors: Fadi Charchar (Federation University), Chris Lau (University of California - San Francisco), and Tatsuo Kido (University of California - San Francisco)

    Submission deadline: September 1, 2021 

    Submit your manuscript


Society News

The most recent SCBA Society news can be accessed on their website here. 

Aims and scope

Cell & Bioscience, the official journal of the Society of Chinese Bioscientists in America, is an open access, peer-reviewed journal that encompasses all areas of life science research.

Dr Yun-Fai Chris Lau, Editor-in-Chief

New Content ItemDr Lau is a Professor at the University of California, San Francisco, and a Research Career Scientist of the San Francisco VA Health Care System. After serving as a founding Associate Editor of the Editorial Board, he has been appointed as the Editor-in-Chief of Cell & Bioscience, effective January 1, 2020. Dr Lau received his B.A. in Chemistry from the Harpur College at the Binghamton University in 1973, and his M.Sc. in 1976 and Ph.D. in 1979 in Cell Biology from the M.D. Anderson-UT Health Graduate School of Biomedical Science at Houston, Texas.  Dr Lau is interested in understanding the functions of genes on the male-specific Y chromosome and their X-homologues in sex determination and sex differences in human diseases and cancers, using molecular genetics, genomics and transgenic strategies. Read more about Dr Lau here.

Introducing our Associate Editors-in-Chief

New Content ItemProf Dong-Yan Jin: Prof Jin did his PhD study with Prof. Yun-De Hou at the State Key Laboratory for Molecular Virology in Beijing in 1986-1991. He received postdoctoral training with Dr. Kuan-Teh Jeang at the NIAID, NIH in 1994-1999. He joined the University of Hong Kong in 1999 and is now Clare and Lawrence Fok Professor in Precision Medicine. He is molecular virologist with an interest on viral oncogenesis and innate antiviral response. Read more about Prof Jin here.

Lin MeiDr. Lin Mei: Dr.  Mei is Professor and Chair, Department of Neurosciences; Allen C. Holmes Professor; and Director, Cleveland Brain Health Initiative, Case Western Reserve University School of Medicine, Cleveland, Ohio. Dr. Mei graduated from Jiangxi Medical College, Nanchang University. After earning PhD in Pharmacology and Toxicology at University of Arizona, he went to Johns Hopkins University School of Medicine for postdoctoral training. Dr. Mei is interested in synapse formation and plasticity. Read more about Dr. Mei here.

New Content ItemDr Ying E Zhang: Dr. Zhang is a Senior Investigator of the Center for Cancer Research at the National Cancer Institute, National Institutes of Health. Dr. Zhang received her B.A. in Chemistry and M.Sc. in Biochemistry from Peking University, Beijing, China, and her Ph.D. in Biomolecular Chemistry from the University of Wisconsin-Madison. In 2000, she joined the National Cancer Institute, National Institutes of Health to continue her research in TGF-beta signaling using a combination of biochemical, genomic and and mouse genetic approaches. Read more about Dr Zhang here.

Trending articles

Click here to view which Articles have been shared the most in the last month!

Affiliated with

Annual Journal Metrics